ORTINGLOBE vs ZYDUSLIFE: Stock Comparison

ORTIN GLOBAL LIMITED vs Zydus Lifesciences Ltd

Live data: 10 June 2026, 4:08 PM IST • Source: NSE and company filings

Zydus Lifesciences Ltd is the larger company by market capitalisation. Zydus Lifesciences Ltd shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of ORTIN GLOBAL LIMITED and Zydus Lifesciences Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ORTINGLOBE is more favourable on 0 of 10 scored metrics and ZYDUSLIFE on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ZYDUSLIFE is the larger company
₹1.12 L Cr vs ₹12 Cr
EPS
ZYDUSLIFE has higher earnings per share
₹50.1 vs ₹-1.13
Dividend Yield
ZYDUSLIFE has a higher dividend yield
0.09% vs 0%
Revenue Growth (TTM YoY)
ZYDUSLIFE has faster revenue growth
16.2% vs -76.86%
EPS Growth (TTM YoY)
ZYDUSLIFE has faster EPS growth
8.7% vs 0%
Qtr Sales Growth
ZYDUSLIFE has stronger quarterly sales growth
16.2% vs 0%
Qtr Profit Growth
ZYDUSLIFE has stronger quarterly profit growth
21.9% vs 0%
ROE
ZYDUSLIFE has a higher ROE
21.2% vs -59.85%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricORTINGLOBEZYDUSLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricORTINGLOBEZYDUSLIFE
Live Price₹18.02₹1,120.5
Day Change0.5%-1.98%
Volume48,80112.75 L
52-Week High₹21.3₹1,181.5
52-Week Low₹10.86₹835.5
Distance from 52W High-15.4%-5.16%

Valuation

MetricORTINGLOBEZYDUSLIFE
Market Cap₹12 Cr₹1.12 L Cr
P/E Ratio22.82x
P/B Ratio4.24x
EPS₹-1.13₹50.1
Book Value₹2.43₹269
Dividend Yield0%0.09%

Growth

MetricORTINGLOBEZYDUSLIFE
Revenue Growth (TTM YoY)-76.86%16.2%
EPS Growth (TTM YoY)0%8.7%
Qtr Sales Growth0%16.2%
Qtr Profit Growth0%21.9%

Profitability & Leverage

MetricORTINGLOBEZYDUSLIFE
ROE-59.85%21.2%
ROCE0%21.1%
Net Margin-529.87%18.36%
Operating Margin31.2%
Debt to Equity0.81x0.46x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricORTINGLOBEZYDUSLIFE
Promoter Holding1.23%75.01% 0.01 pp
FII Holding1.68%6.88% 0.07 pp
DII Holding0%11.27% 0.07 pp
Public Holding97.09%6.83% 0.03 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ORTIN GLOBAL LIMITED and Zydus Lifesciences Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.